A detailed history of Wetherby Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wetherby Asset Management Inc holds 123,598 shares of MRK stock, worth $12.1 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
123,598
Previous 126,686 2.44%
Holding current value
$12.1 Million
Previous $15.7 Million 10.51%
% of portfolio
0.66%
Previous 0.75%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $343,231 - $398,259
-3,088 Reduced 2.44%
123,598 $14 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $852,115 - $915,163
6,883 Added 5.75%
126,686 $15.7 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $514,902 - $599,976
-4,547 Reduced 3.66%
119,803 $15.8 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $93,467 - $101,715
933 Added 0.76%
124,350 $13.6 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $75,153 - $83,460
-730 Reduced 0.59%
123,417 $12.7 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $25,414 - $27,700
-234 Reduced 0.19%
124,147 $14.3 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $339,084 - $378,348
3,294 Added 2.72%
124,381 $13.2 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $168,234 - $215,699
1,924 Added 1.61%
121,087 $13.4 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $226,793 - $254,777
2,683 Added 2.3%
119,163 $10.3 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $370,862 - $420,390
4,442 Added 3.96%
116,480 $10.6 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $209,944 - $235,334
2,856 Added 2.62%
112,038 $9.19 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $3,686 - $4,617
-51 Reduced 0.05%
109,182 $8.37 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $196,976 - $216,624
2,748 Added 2.58%
109,233 $8.2 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $109,121 - $120,699
1,552 Added 1.48%
106,485 $8.28 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $660,229 - $777,682
-9,588 Reduced 8.37%
104,933 $8.09 Million
Q4 2020

Feb 11, 2021

BUY
$71.77 - $79.65 $285,357 - $316,688
3,976 Added 3.6%
114,521 $9.37 Million
Q3 2020

Dec 16, 2020

SELL
$73.18 - $82.95 $543,727 - $616,318
-7,430 Reduced 6.3%
110,545 $9.17 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $807,468 - $915,270
11,034 Added 10.32%
117,975 $9.79 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $619,062 - $704,422
8,791 Added 8.96%
106,941 $8.27 Million
Q1 2020

May 06, 2020

BUY
$63.36 - $87.82 $2.45 Million - $3.4 Million
38,740 Added 65.21%
98,150 $7.55 Million
Q4 2019

Jan 28, 2020

SELL
$77.58 - $87.54 $3.1 Million - $3.49 Million
-39,908 Reduced 40.18%
59,410 $5.4 Million
Q3 2019

Oct 31, 2019

BUY
$76.08 - $82.93 $89,394 - $97,442
1,175 Added 1.2%
99,318 $8.36 Million
Q2 2019

Jul 25, 2019

BUY
$69.84 - $81.59 $73,122 - $85,424
1,047 Added 1.08%
98,143 $8.23 Million
Q1 2019

May 09, 2019

BUY
$69.58 - $79.36 $99,012 - $112,929
1,423 Added 1.49%
97,096 $8.08 Million
Q4 2018

Jan 30, 2019

BUY
$65.24 - $75.71 $156,967 - $182,158
2,406 Added 2.58%
95,673 $7.31 Million
Q3 2018

Nov 07, 2018

SELL
$57.69 - $67.84 $56,420 - $66,347
-978 Reduced 1.04%
93,267 $6.62 Million
Q2 2018

Jul 24, 2018

BUY
$50.83 - $59.72 $85,648 - $100,628
1,685 Added 1.82%
94,245 $5.72 Million
Q1 2018

May 04, 2018

BUY
$50.96 - $59.23 $67,980 - $79,012
1,334 Added 1.46%
92,560 $5.04 Million
Q4 2017

Feb 09, 2018

SELL
$51.62 - $61.64 $90,902 - $108,548
-1,761 Reduced 1.89%
91,226 $5.13 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $5.46 Million - $5.87 Million
92,987
92,987 $5.95 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.